Skip to content
Wall Street PR

Wall Street PR

  • Home
  • Recent Stories
  • Market News
  • Crypto
  • FB
  • TW
  • YT
  • TIKTOK

Ad code paste Below

CMXI

Announcement Of Showcasing AutoloGel System At Advanced Wound Care Symposium Fails To Stop Slide At Cytomedix (CMXI)

The failure to clinch a licensing contract for the flagship product AutoloGel from a top-20 global pharmaceutical company continues to haunt the fully integrated regenerative […]

Cytomedix Has Traders Reaching For The Dramimine (CMXI)

After gapping higher eight days ago on news that Medicare would cover its Autolougous PRP Gel in the treatment of chronic wounds, shares of Cytomedix […]

Cytomedix Share Price Surges After Coverage Determination Granted by CMS (CMXI)

Cytomedix (OTC: CMXI) staged a huge rally in today’s trading session after informing the public that the Center for Medicare & Medicaid Services (CMS) granted […]

Medicare Coverage Heals A Painful Summer For Cytomedix (CMXI)

A dismal summer for Cytomedix (OTC: CMXI) stock suddenly turned a little brighter today. The Centers for Medicare and Medicaid Services announced that they had approved coverage for […]

About WallStreetPR

WallStreetPR.com is a comprehensive publisher reporting on the pulse of the North American stock markets. The site is an innovator in business news, videos and insightful market content that generates hundreds of articles weekly. From Wall Street to Bay Street, WallStreetPR.com covers news from companies big and small with our journalists

Social Menu WallStreetPR

  • FB
  • TW
  • YT
  • TIKTOK

Stocks

  • Featured
  • Latest
  • OTC
  • Nasdaq
  • NYSE
  • Blockchain News
  • Digital News
  • Stock Reports
  • Cryptocurrency
  • Cannabis
  • Advancers
  • Automobile
  • Banking
  • Business
  • Decliners
  • Energy
  • Health
  • Hot News
  • Industrials
  • International
  • Media
  • Metals
  • Mining
  • NASDAQ high profiles
  • Retail
  • Rumors
  • Small Cap Stock News
  • Technology
  • Pot Stocks

Quick Links

  • About Us
  • Contact
  • Privacy Policy
  • Disclaimer
  • Advertise
Copyright © 2019 - 2023 Wall Street PR . All rights reserved.
Wall Street PR
  • FB
  • TW
  • YT
  • TIKTOK
  • Home
  • Recent Stories
  • Market News
  • Crypto